
|Articles|June 1, 2004
- Pharmaceutical Executive-06-01-2004
June 2004 Table of Contents
June 2004 Table of Contents
Advertisement
Articles in this issue
almost 22 years ago
Why Alliances Failalmost 22 years ago
Hire Expectationsalmost 22 years ago
DTC's Next ChapterAdvertisement
Advertisement
Advertisement
Trending on PharmExec
1
FDA Makes Leadership Overhaul Following Commissioner Makary’s Departure: Report
2
The Risks and Benefits of FDA Reviewing Real-Time Data
3
Regeneron Enters $2.3 Billion Collaboration with Parabilis Medicines to Discover & Develop Multiple Therapeutic Candidates
4
FDA Approves Baxdrostat for Uncontrolled Hypertension in First-in-Class Entry
5




